M/Z: 339.2391


Hit 2 annotations:  Propoxyphene_[M-H2O+NH4]+; Pelanin_[M+H-H2O]+


在BioDeep NovoCell知识数据库中,参考离子总共被划分为4个级别。
  • Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
  • Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
  • Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
  • Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。

Found 5 Reference Ions Near m/z 339.2391
NovoCell ID m/z Mass Window Metabolite Ranking Anatomy Context
MSI_000053304 Reliable 339.2296 339.2292 ~ 339.2299
MzDiff: 2.9 ppm
Pregnenolone (BioDeep_00000001411)
Formula: C21H32O2 (316.2402)
8.02 (100%) DESI
[NOVOCELL:BACKGROUND] blank
MSI_000007068 Reliable 339.2465 339.2461 ~ 339.2469
MzDiff: 3.4 ppm
Propoxyphene (BioDeep_00000001945)
Formula: C22H29NO2 (339.2198)
8.41 (100%) Rattus norvegicus
[UBERON:0004359] corpus epididymis
MSI_000008383 Reliable 339.2464 339.2461 ~ 339.2469
MzDiff: 3.4 ppm
Propoxyphene (BioDeep_00000001945)
Formula: C22H29NO2 (339.2198)
7 (100%) Rattus norvegicus
[UBERON:0004360] cauda epididymis
MSI_000055762 Unreliable 339.2304 339.2304 ~ 339.2304
MzDiff: none
Pregnenolone (BioDeep_00000001411)
Formula: C21H32O2 (316.2402)
0.31 (100%) Homo sapiens
[UBERON:0007779] transudate
MSI_000057346 Unreliable 339.2391 339.2391 ~ 339.2391
MzDiff: none
Propoxyphene (BioDeep_00000001945)
Formula: C22H29NO2 (339.2198)
1.11 (100%) Homo sapiens
[UBERON:0007779] transudate

Found 3 Sample Hits
Metabolite Species Sample
Propoxyphene

Formula: C22H29NO2 (339.2198)
Adducts: [M-H2O+NH4]+ (Ppm: 12.3)
Homo sapiens (Liver)
20171107_FIT4_DHBpos_p70_s50
Resolution: 50μm, 70x70

Description

Propoxyphene

Formula: C22H29NO2 (339.2198)
Adducts: [M-H2O+NH4]+ (Ppm: 11.7)
Homo sapiens (esophagus)
LNTO22_1_4
Resolution: 17μm, 82x80

Description

Pelanin

Formula: C23H32O3 (356.2351)
Adducts: [M+H-H2O]+ (Ppm: 12.8)
Homo sapiens (colorectal adenocarcinoma)
80TopL, 50TopR, 70BottomL, 60BottomR-profile
Resolution: 17μm, 137x136

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).